HPHC testing delayed by US FDA

It was an expected move. The U.S. Food and Drug Administration (FDA) has extended the Harmful and Potentially Harmful Constituents (HPHCs) reporting compliance date. The deadline was Nov. 8, 2019. The new deadline is not a firm date.

The new deadline is six months for large manufacturers and nine months for smaller manufacturers after the FDA releases guidance for how the testing will be conducted.

Small scale manufacturers is an FDA defined term for companies that generate less than $5 million in revenue and have less than 150 employees.